Join to view full profile
1275 York AveNew York, NY 10065
Phone+1 646-227-3813
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kapil Dhingra, MD is an oncologist in New York, New York. He is currently licensed to practice medicine in New York, North Dakota, and Texas.
Education & Training
Emory University School of MedicineFellowship, Hematology and Medical Oncology, 1986 - 1988
Lincoln Medical and Mental Health CenterResidency, Internal Medicine, 1983 - 1986
All India Institute of Medical SciencesClass of 1981
Certifications & Licensure
NY State Medical License 1986 - 2028
TX State Medical License 1987 - 2026
GA State Medical License 1986 - 1993
MD State Medical License 1984 - 1992
ND State Medical License 1988 - 1991
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 19 citationsOncology 2020: a drug development and approval paradigmKapil Dhingra
Annals of Oncology. 2015-11-01 - 2 citations“Industry Corner: Perspectives and Controversies” A New Series in Annals of OncologyKapil Dhingra
Annals of Oncology. 2015-07-01 - 1 citationsPhase II trial of 10-EDAM in the treatment of metastatic breast cancerGarth Beinart, Ana M. Gonzalez-Angulo, Kristine Broglio, Debbie Frye, Ronald S. Walters
Cancer Chemotherapy and Pharmacology. 2007-06-01
Press Mentions
Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic AdvisorMarch 3rd, 2022- Medicenna Announces Appointment of Clinical Advisory Board and Dr. Kapil Dhingra as Strategic AdvisorMarch 3rd, 2022
- Black Diamond Therapeutics Announces Appointment of Oncology Clinical Development Veteran Dr. Kapil Dhingra to Board of DirectorsJanuary 20th, 2021
